These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

531 related articles for article (PubMed ID: 22393941)

  • 81. Bacterial resistance mechanism: what proteomics can elucidate.
    Lima TB; Pinto MF; Ribeiro SM; de Lima LA; Viana JC; Gomes Júnior N; Cândido Ede S; Dias SC; Franco OL
    FASEB J; 2013 Apr; 27(4):1291-303. PubMed ID: 23349550
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Advances and strategies in discovery of new antibacterials for combating metabolically resting bacteria.
    Bald D; Koul A
    Drug Discov Today; 2013 Mar; 18(5-6):250-5. PubMed ID: 23032727
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Context matters - the complex interplay between resistome genotypes and resistance phenotypes.
    Dantas G; Sommer MO
    Curr Opin Microbiol; 2012 Oct; 15(5):577-82. PubMed ID: 22954750
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Lack of development of new antimicrobial drugs: a potential serious threat to public health.
    Norrby SR; Nord CE; Finch R;
    Lancet Infect Dis; 2005 Feb; 5(2):115-9. PubMed ID: 15680781
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Alternatives to antibiotics-a pipeline portfolio review.
    Czaplewski L; Bax R; Clokie M; Dawson M; Fairhead H; Fischetti VA; Foster S; Gilmore BF; Hancock RE; Harper D; Henderson IR; Hilpert K; Jones BV; Kadioglu A; Knowles D; Ólafsdóttir S; Payne D; Projan S; Shaunak S; Silverman J; Thomas CM; Trust TJ; Warn P; Rex JH
    Lancet Infect Dis; 2016 Feb; 16(2):239-51. PubMed ID: 26795692
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Strategies to Overcome Antimicrobial Resistance (AMR) Making Use of Non-Essential Target Inhibitors: A Review.
    Annunziato G
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31766441
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Molecules that Inhibit Bacterial Resistance Enzymes.
    Liu Y; Li R; Xiao X; Wang Z
    Molecules; 2018 Dec; 24(1):. PubMed ID: 30583527
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Diagnostics and Resistance Profiling of Bacterial Pathogens.
    Hornischer K; Häußler S
    Curr Top Microbiol Immunol; 2016; 398():89-102. PubMed ID: 27474081
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Current Technology in the Discovery and Development of Novel Antibacterials.
    Chung PY
    Curr Drug Targets; 2018; 19(7):832-840. PubMed ID: 28891454
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Resistant no more: new antibiotics on the horizon. Present-day antibiotics may be superseded by a new class of bacteria-killing drugs.
    Duke Med Health News; 2014 Apr; 20(4):1-2. PubMed ID: 25195206
    [No Abstract]   [Full Text] [Related]  

  • 91. Multitarget ligands in antibacterial research: progress and opportunities.
    East SP; Silver LL
    Expert Opin Drug Discov; 2013 Feb; 8(2):143-56. PubMed ID: 23252414
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Counteracting antibiotic resistance: breaking barriers among antibacterial strategies.
    Baquero F; Coque TM; Cantón R
    Expert Opin Ther Targets; 2014 Aug; 18(8):851-61. PubMed ID: 24881465
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Novel approaches to developing new antibiotics for bacterial infections.
    Coates AR; Hu Y
    Br J Pharmacol; 2007 Dec; 152(8):1147-54. PubMed ID: 17704820
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Blast from the Past: Reassessing Forgotten Translation Inhibitors, Antibiotic Selectivity, and Resistance Mechanisms to Aid Drug Development.
    Arenz S; Wilson DN
    Mol Cell; 2016 Jan; 61(1):3-14. PubMed ID: 26585390
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Antibiotic Resistance: The Need For a Global Strategy.
    Elder DP; Kuentz M; Holm R
    J Pharm Sci; 2016 Aug; 105(8):2278-87. PubMed ID: 27397433
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Antibiotic adjuvants - A strategy to unlock bacterial resistance to antibiotics.
    González-Bello C
    Bioorg Med Chem Lett; 2017 Sep; 27(18):4221-4228. PubMed ID: 28827113
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Transcriptional regulators: valuable targets for novel antibacterial strategies.
    González A; Fillat MF; Lanas Á
    Future Med Chem; 2018 Mar; 10(5):541-560. PubMed ID: 29461098
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Better living through chemistry: Addressing emerging antibiotic resistance.
    Coussens NP; Molinaro AL; Culbertson KJ; Peryea T; Zahoránszky-Köhalmi G; Hall MD; Daines DA
    Exp Biol Med (Maywood); 2018 Mar; 243(6):538-553. PubMed ID: 29409348
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Unconventional screening approaches for antibiotic discovery.
    Farha MA; Brown ED
    Ann N Y Acad Sci; 2015 Sep; 1354():54-66. PubMed ID: 26100135
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Metabolite concentration as a criterion for antibacterial discovery.
    Wang ZY; Zhu Q; Zhang HY
    Curr Comput Aided Drug Des; 2013 Sep; 9(3):412-6. PubMed ID: 24010936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.